Literature DB >> 22810965

Comparison of retinal nerve fiber layer thickness measurements by spectral-domain optical coherence tomography systems using a phantom eye model.

Roy de Kinkelder1, Daniel M de Bruin, Frank D Verbraak, Ton G van Leeuwen, Dirk J Faber.   

Abstract

To quantify differences in nerve fiber layer thickness measurements by various spectral-domain optical coherence tomography (SD-OCT) systems, we developed a phantom eye model. We tested twelve SD-OCT systems of four manufacturers. All systems combined overestimated the 49 µm thick phantom RNFL thickness on average by 18 µm. Within brands, thickness measurements differed statistically significant for one Topcon, one RTVue and one Cirrus. Between brands, thickness determined with RTVue and Topcon differed statistically significant from Cirrus and Spectralis. The maximum difference between mean thicknesses is 3.6 µm within brands and 7.7 µm between brands.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Year:  2012        PMID: 22810965     DOI: 10.1002/jbio.201200018

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  10 in total

1.  Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography.

Authors:  Sina Farsiu; Stephanie J Chiu; Rachelle V O'Connell; Francisco A Folgar; Eric Yuan; Joseph A Izatt; Cynthia A Toth
Journal:  Ophthalmology       Date:  2013-08-29       Impact factor: 12.079

2.  In vivo, percutaneous, needle based, optical coherence tomography of renal masses.

Authors:  Peter G Wagstaff; Abel Swaan; Alexandre Ingels; Patricia J Zondervan; Otto M van Delden; Dirk J Faber; Ton G van Leeuwen; Jean J de la Rosette; Daniel M de Bruin; M Pilar Laguna Pes
Journal:  J Vis Exp       Date:  2015-03-30       Impact factor: 1.355

3.  Influence of coherence length, signal-to-noise ratio, log transform, and low-pass filtering on layer thickness assessment with OCT in the retina.

Authors:  Nomdo M Jansonius; Joel Cervantes; Maddipatla Reddikumar; Barry Cense
Journal:  Biomed Opt Express       Date:  2016-10-07       Impact factor: 3.732

4.  Lateral and axial measurement differences between spectral-domain optical coherence tomography systems.

Authors:  Francisco A Folgar; Eric L Yuan; Sina Farsiu; Cynthia A Toth
Journal:  J Biomed Opt       Date:  2014-01       Impact factor: 3.170

5.  Testing a phantom eye under various signal-to-noise ratio conditions using eleven different OCT devices.

Authors:  Tuomas Heikka; Giovanni Ometto; Giovanni Montesano; Scott Rowe; Nomdo M Jansonius; David P Crabb
Journal:  Biomed Opt Express       Date:  2020-02-07       Impact factor: 3.732

6.  Optical coherence tomography for advanced screening in the primary care office.

Authors:  Ryan L Shelton; Woonggyu Jung; Samir I Sayegh; Daniel T McCormick; Jeehyun Kim; Stephen A Boppart
Journal:  J Biophotonics       Date:  2013-04-18       Impact factor: 3.207

7.  Retina phantom for the evaluation of optical coherence tomography angiography based on microfluidic channels.

Authors:  Hyun-Ji Lee; Nafra M Samiudin; Tae Geol Lee; Il Doh; Sang-Won Lee
Journal:  Biomed Opt Express       Date:  2019-10-03       Impact factor: 3.732

8.  Objective determination of optimal number of spectral-domain optical coherence tomographic images of retina to average.

Authors:  Makoto Shirasawa; Taiji Sakamoto; Hiroto Terasaki; Takehiro Yamashita; Eisuke Uchino; Shozo Sonoda
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

9.  Optic Nerve Head Measurements With Optical Coherence Tomography: A Phantom-Based Study Reveals Differences Among Clinical Devices.

Authors:  Anant Agrawal; Jigesh Baxi; William Calhoun; Chieh-Li Chen; Hiroshi Ishikawa; Joel S Schuman; Gadi Wollstein; Daniel X Hammer
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

10.  Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.

Authors:  A M E Schauwvlieghe; G Dijkman; J M Hooymans; F D Verbraak; C B Hoyng; M G W Dijkgraaf; T Peto; J R Vingerling; R O Schlingemann
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.